<- Go home

Added to YB: 2026-07-07

Pitch date: 2026-03-31

BLLN [bullish]

BillionToOne, Inc.

+58.94%

current return

Author Info

No bio for this author

Company Info

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.

Market Cap

$5.5B

Pitch Price

$77.64

Price Target

N/A

Dividend

N/A

EV/EBITDA

87.07

P/E

153.47

EV/Sales

14.50

Sector

Health Care Providers and Services

Category

growth

Show full summary:
Baron Health Care Fund New Position: BillionToOne, Inc.

BLLN (new position): Diagnostics disruptor via QCT tech enabling single-gene mutation counting. UNITY prenatal test captured 15% of $2B+ US market fast, gaining share. Oncology nascent ($50B+ TAM): NORTHSTAR SELECT finds 51-109% more mutations; RESPONSE data may unlock Medicare. 70% GM, GAAP profitable, FCF+.

Read full article (2 min)